03
August
2022


Share on networks

The German company Merck has invested 14.5 million euros in its facilities in Mollet del Vallès (Barcelona). This large investment will meet increased demand for the company’s specific products in its Life Sciences sector, such as the production of some Covid-19 vaccines.

The expansion project is a further demonstration of the Merck Group’s commitment to its operations in Catalonia while reinforcing its commitment to international supply solutions at this site, as production from the new building will be exported around the world.

Miguel Fernández Alcalde, Managing Director of Merck in Spain, said: “In the last 4 years Merck has invested a total of 90 million euros in the Mollet del Vallès site and in the biotechnology plant in Tres Cantos (Madrid). This has had a clear impact on our production and export capacity from Spain. Specifically, around 99% of the production developed at the Mollet del Vallès site is exported to other countries”.

Share on networks

Related news

Saló Nàutic de Barcelona

News

Successful Saló Nàutic closes with 50.000 visitors and more than 700 vessels

Universitat de Barcelona

News

Barcelona is home to 3 of the best universities in the world according to the THE Ranking

Barcelona Cable Landing Station

News

By the end of this year the Barcelona Cable Landing Station will be ready to receive the first submarine cables.